1.
Popa S. New approaches in modulating the GLP-1/GLP-2 AXIS: link between metabolic diseases and inflammatory bowel disease. RJDNMD [Internet]. 30Sep.2022 [cited 18Feb.2025];29(3):376-80. Available from: https://rjdnmd.org/index.php/RJDNMD/article/view/1181